CDRL

Latest SEC Filings & News for CDRL

1 most recent filing and news item mentioning CDRL. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day

curl "https://api.brieftape.com/v1/tickers/CDRL/news?limit=20"

Pull CDRL filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

LeadershipJun 3, 2026Negative

Cadrenal Therapeutics CFO Matthew Szot separated from company effective May 28, 2026

Matthew K. Szot, Chief Financial Officer of Cadrenal Therapeutics, separated from the company on May 28, 2026, with a severance package of $365,806 payable in installments through September 2026. The departure represents a leadership change at the biopharmaceutical company during

View filing at SEC.gov →

AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.